Nasdaq

Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14, ...
Seeking Alpha

Theratechnologies Receives Refusal to File Letter for Trogarzo® Intramuscular Method of Administration sBLA from FDA

MONTREAL, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TH:CA) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today ...
News-Medical.Net

Prime and pull vaccine approach prevents genital herpes infection

Genital herpes is a lifelong infection. While available treatments can manage symptoms, they cannot cure the infection or ...

Prime-and-pull vaccine may offer lasting genital herpes protection

Genital herpes is a lifelong infection. While available treatments can manage symptoms, they cannot cure the infection or ...
Technology Networks

Two-Step Herpes Vaccine Combines IM Shot with Vaginal Nanoparticle Delivery

A nanoparticle-based “prime and pull” vaccine strategy resulted in strong immune responses in vaginal tissue. In preclinical ...
Business Insider

Theratechnologies Files SBLA For Trogarzo Intramuscular Method Of Administration With FDA

(RTTNews) - Biopharmaceutical company Theratechnologies Inc. (THTX, TH.TO) announced Tuesday the filing of a supplemental Biologics License Application (sBLA) for an intramuscular (IM) method of ...